Bellevue Group »

C4 Therapeutics shares owned by Bellevue Group

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Bellevue Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $350k 62k 5.65
2022-03-31 $1.3M 55k 24.26
2021-12-31 $1.5M 47k 32.20
2021-09-30 $2.1M 47k 44.68
2021-06-30 $1.2M 31k 37.84